NO20074670L - Indolforbindelser og anvendelse derav - Google Patents

Indolforbindelser og anvendelse derav

Info

Publication number: NO20074670L
Authority: NO; Norway
Prior art keywords: sinusitis; disease; pneumonia; prodrug; solvate
Prior art date: 2005-02-25

Application number

NO20074670A

Other languages

English (en)

Norwegian (no)

Inventor

Yoshisuke Nakayama

Jun Takeuchi

Manabu Fujita

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-02-25

Filing date

2007-09-13

Publication date

2007-11-19

2007-09-13 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2007-11-19 Publication of NO20074670L publication Critical patent/NO20074670L/no

Links

150000002475 indoles Chemical class 0.000 title 1
206010035664 Pneumonia Diseases 0.000 abstract 2
201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
239000000651 prodrug Substances 0.000 abstract 2
229940002612 prodrug Drugs 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
239000012453 solvate Substances 0.000 abstract 2
206010001052 Acute respiratory distress syndrome Diseases 0.000 abstract 1
206010001076 Acute sinusitis Diseases 0.000 abstract 1
206010006458 Bronchitis chronic Diseases 0.000 abstract 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
206010009137 Chronic sinusitis Diseases 0.000 abstract 1
206010014561 Emphysema Diseases 0.000 abstract 1
230000001154 acute effect Effects 0.000 abstract 1
201000000028 adult respiratory distress syndrome Diseases 0.000 abstract 1
230000000954 anitussive effect Effects 0.000 abstract 1
229940124584 antitussives Drugs 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
206010006451 bronchitis Diseases 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
208000007451 chronic bronchitis Diseases 0.000 abstract 1
208000027157 chronic rhinosinusitis Diseases 0.000 abstract 1
PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
239000003172 expectorant agent Substances 0.000 abstract 1
230000003419 expectorant effect Effects 0.000 abstract 1
208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
229940065725 leukotriene receptor antagonists for obstructive airway diseases Drugs 0.000 abstract 1
239000003199 leukotriene receptor blocking agent Substances 0.000 abstract 1
150000002617 leukotrienes Chemical class 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
229940044551 receptor antagonist Drugs 0.000 abstract 1
239000002464 receptor antagonist Substances 0.000 abstract 1
230000000241 respiratory effect Effects 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1
201000009890 sinusitis Diseases 0.000 abstract 1
208000011580 syndromic disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20074670A 2005-02-25 2007-09-13 Indolforbindelser og anvendelse derav NO20074670L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2005051392		2005-02-25
JP2005352787		2005-12-07
PCT/JP2006/303374 WO2006090817A1 (ja)	2005-02-25	2006-02-24	インドール化合物およびその用途

Publications (1)

Publication Number	Publication Date
NO20074670L true NO20074670L (no)	2007-11-19

Family

ID=36927451

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20074670A NO20074670L (no)	2005-02-25	2007-09-13	Indolforbindelser og anvendelse derav

Country Status (15)

Country	Link
US (1)	US7728023B2 (pt)
EP (1)	EP1852420B1 (pt)
JP (1)	JP5024039B2 (pt)
KR (1)	KR101377790B1 (pt)
CN (1)	CN101128424A (pt)
AU (1)	AU2006216170B2 (pt)
BR (1)	BRPI0606870A2 (pt)
CA (1)	CA2599348C (pt)
ES (1)	ES2395929T3 (pt)
IL (1)	IL185199A (pt)
MX (1)	MX2007010112A (pt)
NO (1)	NO20074670L (pt)
NZ (1)	NZ560513A (pt)
RU (1)	RU2416601C2 (pt)
WO (1)	WO2006090817A1 (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE50453E1 (en)	2006-04-07	2025-06-10	Vertex Pharmaceuticals Incorporated	Indole derivatives as CFTR modulators
US7645789B2 (en)	2006-04-07	2010-01-12	Vertex Pharmaceuticals Incorporated	Indole derivatives as CFTR modulators
NZ596889A (en)	2006-04-07	2013-06-28	Vertex Pharma	Use of amide indole derivatives as modulators of ATP-binding cassette transporters
US10022352B2 (en)	2006-04-07	2018-07-17	Vertex Pharmaceuticals Incorporated	Modulators of ATP-binding cassette transporters
KR101411820B1 (ko)	2006-08-07	2014-06-24	액테리온 파마슈티칼 리미티드	(3-아미노-1,2,3,4-테트라하이드로-9ｈ-카르바졸-9-일)-아세트산 유도체
US8563573B2 (en)	2007-11-02	2013-10-22	Vertex Pharmaceuticals Incorporated	Azaindole derivatives as CFTR modulators
JO2701B1 (en)	2006-12-21	2013-03-03	جلاكسو جروب ليميتد	Vehicles
CA2682356C (en) *	2007-04-16	2016-06-14	Abbott Laboratories	7-substituted indole mcl-1 inhibitors
BRPI0809472A2 (pt)	2007-04-19	2014-09-09	Glaxo Group Ltd	Derivados indazol substituídos com oxadiazol para emprego como agonistas de esfingosina 1-fosfato (sip)
JP5086027B2 (ja) *	2007-10-15	2012-11-28	株式会社Ａｄｅｋａ	インドリウム化合物及び該化合物を用いた光学記録材料
GB0807910D0 (en) *	2008-04-30	2008-06-04	Glaxo Group Ltd	Compounds
RU2393149C2 (ru) *	2008-05-28	2010-06-27	Общество с ограниченной ответственностью "Интеллектуальный Диалог"	Замещенные [4(6)-бром-5-гидрокси-1н-индол-3-ил]уксусные кислоты и их эфиры, фокусированная библиотека, противовирусный препарат и фармацевтическая композиция
US20100010053A1 (en) *	2008-06-20	2010-01-14	Jose Luis Castro Pineiro	Compounds
TWI469965B (zh) *	2008-12-22	2015-01-21	Ono Pharmaceutical Co	乙炔基吲哚化合物
WO2010127452A1 (en) *	2009-05-04	2010-11-11	The Royal Institution For The Advancement Of Learning/Mcgill University	5-oxo-ete receptor antagonist compounds
US9790186B2 (en)	2009-07-21	2017-10-17	Trustees Of Dartmouth College	Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection
WO2011117798A1 (en)	2010-03-22	2011-09-29	Actelion Pharmaceuticals Ltd	3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
US8802868B2 (en)	2010-03-25	2014-08-12	Vertex Pharmaceuticals Incorporated	Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
RU2745977C2 (ru)	2010-04-22	2021-04-05	Вертекс Фармасьютикалз Инкорпорейтед	Способ получения циклоалкилкарбоксамидо-индольных соединений
AU2011270297B2 (en) *	2010-06-21	2014-07-03	Ono Pharmaceutical Co., Ltd.	Novel crystalline forms of 4,4'-[4-fluoro-7-({4-[4-(3-fluoro-2-methylphenyl)butoxy] phenyl}ethynyl)-2-methyl-1h-indole-1,3-diyl]dibutanoic acid,4,4'- [2-methyl-7-({4-[4-(pentafluorophenyl) butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid, and 4,4'-[4-fluoro-2-methyl-7- ({4-[4-(2,3,4,6-tetrafluorophenyl) butoxy]phenyl}ethynyl)-1h-indole-1,3-diyl]dibutanoic acid
MY165623A (en)	2011-04-14	2018-04-18	Idorsia Pharmaceuticals Ltd	7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
CN103159665B (zh) *	2011-12-09	2017-01-25	天津市国际生物医药联合研究院	对sars冠状病毒主蛋白酶具有抑制作用的靛红‑5‑酰胺类抑制剂
AU2013290444B2 (en)	2012-07-16	2018-04-26	Vertex Pharmaceuticals Incorporated	Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof
WO2014141110A2 (en) *	2013-03-14	2014-09-18	Curadev Pharma Pvt. Ltd.	Aminonitriles as kynurenine pathway inhibitors
EP3097097B1 (en) *	2014-01-21	2017-10-04	F. Hoffmann-La Roche AG	Imidazoles for the treatment and prophylaxis of respiratory syncytial virus infection
HRP20181555T1 (hr)	2014-03-17	2018-11-30	Idorsia Pharmaceuticals Ltd	Derivati azaindol-octene kiseline i njihova uporaba kao modulatora receptora prostaglandina d2
RU2016140708A (ru)	2014-03-18	2018-04-18	Идорсиа Фармасьютиклз Лтд	Производные азаиндол уксусной кислоты и их применение в качестве модуляторов рецептора простагландина d2
SG10201913575VA (en)	2014-04-15	2020-02-27	Vertex Pharma	Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
EP3277665B1 (en) *	2015-03-31	2020-03-04	The Royal Institution for the Advancement of Learning / McGill University	Indole analogs as 5-oxo-ete receptor antagonists and method of use thereof
WO2017035288A1 (en) *	2015-08-27	2017-03-02	Trustees Of Dartmouth College	Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection
PL3350179T3 (pl)	2015-09-15	2021-08-02	Idorsia Pharmaceuticals Ltd	Krystaliczne postacie
CN116832169A (zh) *	2016-09-02	2023-10-03	箭头药业股份有限公司	靶向配体
EP3870292A4 (en)	2018-10-26	2022-11-09	The Research Foundation for The State University of New York	COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA
CN112891343B (zh) *	2021-03-22	2022-04-01	华中农业大学	3-吲哚乙腈在制备抑制新型冠状病毒SARS-CoV-2药物中的应用
WO2023182840A1 (ko) *	2022-03-25	2023-09-28	주식회사 미토이뮨테라퓨틱스	항바이러스용 약학적 조성물 및 이의 용도
CN114874124B (zh) *	2022-05-12	2023-07-04	五邑大学	一种褪黑激素肉桂酸衍生物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8607294D0 (en) *	1985-04-17	1986-04-30	Ici America Inc	Heterocyclic amide derivatives
US5229413A (en)	1989-05-05	1993-07-20	G. D. Searle & Co.	Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
JPH0347123A (ja) *	1989-05-05	1991-02-28	G D Searle & Co	インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
GB8927981D0 (en) *	1989-12-11	1990-02-14	Ici Plc	Carbamoyl derivative
US5530019A (en)	1993-04-05	1996-06-25	Fujisawa Pharmaceutical Co., Ltd.	Indole derivatives useful as testosterone 5α-reductase inhibitors
US5968745A (en)	1995-06-27	1999-10-19	The University Of North Carolina At Chapel Hill	Polymer-electrodes for detecting nucleic acid hybridization and method of use thereof
EP0863873B1 (en) *	1995-10-10	1999-11-10	Pfizer Inc.	Indole carbamates as leukotriene antagonists
GB9902455D0 (en) *	1999-02-05	1999-03-24	Zeneca Ltd	Chemical compounds
US6608059B1 (en)	2000-06-27	2003-08-19	Smithkline Beecham Corporation	Fatty acid synthase inhibitors
US6867224B2 (en)	2002-03-07	2005-03-15	Warner-Lambert Company	Compounds that modulate PPAR activity and methods of preparation
WO2003082271A2 (en)	2002-04-03	2003-10-09	Astrazeneca Ab	Indole derivatives having anti-angiogenetic activity
EP1501797B1 (en) *	2002-04-23	2009-08-05	Aventis Pharmaceuticals Inc.	3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors
SE0202241D0 (sv) *	2002-07-17	2002-07-17	Astrazeneca Ab	Novel Compounds
US7329680B2 (en)	2003-04-30	2008-02-12	The Institute For Pharmaceutical Discovery, Llc	Heterocycle substituted carboxylic acids
MXPA06002152A (es)	2003-09-01	2006-05-22	Ono Pharmaceutical Co	Compuesto de anillo condensado y uso del mismo.

2006
- 2006-02-24 EP EP06714513A patent/EP1852420B1/en not_active Expired - Lifetime
- 2006-02-24 US US11/885,018 patent/US7728023B2/en not_active Expired - Fee Related
- 2006-02-24 ES ES06714513T patent/ES2395929T3/es not_active Expired - Lifetime
- 2006-02-24 KR KR1020077019358A patent/KR101377790B1/ko not_active Expired - Fee Related
- 2006-02-24 AU AU2006216170A patent/AU2006216170B2/en not_active Ceased
- 2006-02-24 NZ NZ560513A patent/NZ560513A/en not_active IP Right Cessation
- 2006-02-24 BR BRPI0606870-7A patent/BRPI0606870A2/pt not_active IP Right Cessation
- 2006-02-24 CA CA2599348A patent/CA2599348C/en not_active Expired - Fee Related
- 2006-02-24 JP JP2007504797A patent/JP5024039B2/ja not_active Expired - Fee Related
- 2006-02-24 CN CNA2006800057910A patent/CN101128424A/zh active Pending
- 2006-02-24 MX MX2007010112A patent/MX2007010112A/es active IP Right Grant
- 2006-02-24 WO PCT/JP2006/303374 patent/WO2006090817A1/ja not_active Ceased
- 2006-02-24 RU RU2007135347/04A patent/RU2416601C2/ru not_active IP Right Cessation
2007
- 2007-08-12 IL IL185199A patent/IL185199A/en not_active IP Right Cessation
- 2007-09-13 NO NO20074670A patent/NO20074670L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL185199A (en)	2014-06-30
KR101377790B1 (ko)	2014-03-27
RU2416601C2 (ru)	2011-04-20
JPWO2006090817A1 (ja)	2008-07-24
RU2007135347A (ru)	2009-03-27
JP5024039B2 (ja)	2012-09-12
AU2006216170B2 (en)	2012-02-09
CA2599348C (en)	2013-07-23
EP1852420B1 (en)	2012-10-17
BRPI0606870A2 (pt)	2009-07-21
CA2599348A1 (en)	2006-08-31
MX2007010112A (es)	2007-10-12
EP1852420A1 (en)	2007-11-07
WO2006090817A1 (ja)	2006-08-31
NZ560513A (en)	2010-07-30
IL185199A0 (en)	2008-01-06
ES2395929T3 (es)	2013-02-18
AU2006216170A1 (en)	2006-08-31
US20080188532A1 (en)	2008-08-07
KR20070114140A (ko)	2007-11-29
CN101128424A (zh)	2008-02-20
US7728023B2 (en)	2010-06-01
EP1852420A4 (en)	2011-06-15

Legal Events

Date	Code	Title	Description
2015-09-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20074670L (no)	2007-11-19	Indolforbindelser og anvendelse derav
NO20083562L (no)	2008-10-20	Cannabinoidreseptormodulatorer
NO20082000L (no)	2008-06-09	Pyrimidinamidforbindelser som PGDS-inhibitorer
NO20091183L (no)	2009-05-08	Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
NO20083658L (no)	2008-10-27	Cyanoisokinolinforbindelser som stabiliserer hypoksi induserbar faktor(HIF)
NO20081014L (no)	2008-04-10	Sammensetninger
CL2011002787A1 (es)	2012-06-22	Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica.
NO20090755L (no)	2009-03-09	Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20082124L (no)	2008-06-20	Bifenyloksyeddiksyrederivater for behandling av respiratorisk sykdom
NO20091326L (no)	2009-04-01	Indazolderivater som modulatorer av interleukin-1-reseptor-assosiert kinase
NO20084005L (no)	2008-09-19	Aminderivater
WO2008027584A3 (en)	2008-06-19	5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
NO20084931L (no)	2009-01-16	Farmasoytiske sammensetninger
WO2009126530A3 (en)	2010-01-14	Piperidine derivatives as cgrp receptor antagonists
NO20082673L (no)	2008-07-23	Nye 2-amino-imidazol-4-on forbindelser og deres anvendelse i fremstilling av et medikament som skal brukes til behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerasjon og demens
NO20063693L (no)	2006-10-23	Forbindelse og metode for anvendelse
NO20084318L (no)	2008-10-15	Inhibitorer av II-beta-hydroksystereoid dehydrogenase I
WO2008094992A3 (en)	2008-12-04	2-aminopyridine derivatives useful as kinase inhibitors
GEAP201813860A (en)	2018-04-10	Novel compounds
BR112012024785A2 (pt)	2016-06-07	antagonista do receptor de cgrp
NO20090266L (no)	2009-03-17	Piperazinylderivater anvendelige i behandlingen av GPR38 receptormedierte sykdommer
JP2016540749A5 (pt)	2017-12-07
NZ589293A (en)	2012-09-28	Antiallergic marine biopolymers comprising iota-carrageenan
EA200970883A1 (ru)	2010-04-30	Индолкарбоксамиды как ингибиторы ikk2
EA201891143A1 (ru)	2018-11-30	Пиперидиноновые агонисты формилпептидного рецептора 2 и формилпептидного рецептора 1